Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$25.8M
-
Put/Call ratio
-
0.8
-
Number of buys
-
51
-
Number of sells
-
-56
-
Price
-
$32.07
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q4 2021
138 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q4 2021.
Pulmonx Corp - COMMON STOCK (LUNG) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 40.4M outstanding shares and own 78.68% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4.94M shares), Capital World Investors (2.75M shares), BlackRock Inc. (2.72M shares), VANGUARD GROUP INC (2.52M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.37M shares), Champlain Investment Partners, LLC (2.09M shares), TimesSquare Capital Management, LLC (1.26M shares), RTW INVESTMENTS, LP (1.16M shares), Miura Global Management, LLC (1.15M shares), and PERCEPTIVE ADVISORS LLC (762K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.